Attention Marinus Pharmaceuticals, Inc. Investors: Deadline for Securities Class Action Looms
Monday, 1 July 2024, 20:24
Attention to Marinus Pharmaceuticals, Inc. Investors:
Key Points:
- ROSEN, a recognized investor counsel, urges investors to act.
- The deadline for a securities class action is approaching.
- Investors in Marinus Pharmaceuticals, Inc. are advised to secure representation.
- The action was first filed by the firm MRNS.
Investors are encouraged to take prompt action to safeguard their interests.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.